Top 2

Photo by Edward Jenner from Pexels

Positive 3-Year AMT-130 Data For Huntington’s From uniQure Bodes Well For Pre-BLA Meeting

Photo by Pavel Danilyuk from Pexels

Novartis To Acquire Tourmaline Bio For $1.4B For Novel IL-6 Inhibitor Pacibekitug

BioMarin Gets Rid Of Palynziq Successor To Treat PKU For Lack Of Goal Being Met

Merck’s $3 Billion Cost-Cutting Measure Is First Step For Intended Future Growth

FDA Alters Course On ELEVIDYS Shipping Pause For Ambulatory DMD Patients

To Expand Cardiopulmonary Pipeline Merck Acquires Verona Pharma For $10 Billion

ProKidney Scores Win With Cell Therapy Rilparencel For CKD Patients

MoonLake Sought Out For By Merck For $3 Billion To Add Sonelokimab To Arsenal, FT Reports

Amazing Survival Feat In Solid Tumors Achieved With Merus Petosemtamab

In Flight To Enact Strategic Alternatives, Tempest Cuts 80% of its Workforce

Scroll to Top